Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1061)
INSMED Inc (INSM)
Lewis William — Director
Shares
2,255
Price
$144.66
Total Value
$326.21K
Shares Held After
302,010
% of Holdings
0.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,373
Price
$143.81
Total Value
$772.69K
Shares Held After
304,265
% of Holdings
1.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,246
Price
$142.99
Total Value
$321.16K
Shares Held After
309,638
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$581.33
Total Value
$93.01K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
385
Price
$579.84
Total Value
$223.24K
Shares Held After
40,673
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,750
Price
$579.36
Total Value
$1.01M
Shares Held After
41,058
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,027
Price
$578.05
Total Value
$1.17M
Shares Held After
42,808
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,048
Price
$577.03
Total Value
$1.18M
Shares Held After
44,835
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
930
Price
$575.99
Total Value
$535.67K
Shares Held After
46,883
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,800
Price
$574.79
Total Value
$1.03M
Shares Held After
47,813
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$573.96
Total Value
$229.58K
Shares Held After
49,613
% of Holdings
0.8%
Whitehawk Therapeutics, Inc. (WHWK)
Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Shares
141,600
Price
$4.13
Total Value
$584.81K
Shares Held After
295,224
% of Holdings
32.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$581.64
Total Value
$23.27K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
160
Price
$581.08
Total Value
$92.97K
Shares Held After
18,916
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,454
Price
$579.64
Total Value
$842.79K
Shares Held After
19,076
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,066
Price
$578.83
Total Value
$617.03K
Shares Held After
20,530
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,085
Price
$577.87
Total Value
$1.20M
Shares Held After
21,596
% of Holdings
8.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,206
Price
$576.91
Total Value
$1.27M
Shares Held After
23,681
% of Holdings
8.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
789
Price
$575.64
Total Value
$454.18K
Shares Held After
25,887
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,680
Price
$574.73
Total Value
$965.55K
Shares Held After
26,676
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$573.91
Total Value
$298.44K
Shares Held After
28,356
% of Holdings
1.8%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$40.31
Total Value
$1.01M
Shares Held After
1,441,934
% of Holdings
1.7%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.18
Total Value
$270.27K
Shares Held After
408,160
% of Holdings
4.5%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
226,906
Price
$45.34
Total Value
$10.29M
Shares Held After
3,020,119
% of Holdings
7.0%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
226,906
Price
$45.34
Total Value
$10.29M
Shares Held After
3,020,119
% of Holdings
7.0%
Aura Biosciences, Inc. (AURA)
Kilroy Conor — Chief Legal Officer and Secretary.
Shares
11,738
Price
$7.02
Total Value
$82.40K
Shares Held After
217,835
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,294
Price
$578.21
Total Value
$748.20K
Shares Held After
45,172
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
3,366
Price
$577.39
Total Value
$1.94M
Shares Held After
46,466
% of Holdings
6.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,800
Price
$576.38
Total Value
$1.04M
Shares Held After
49,832
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,640
Price
$575.37
Total Value
$943.61K
Shares Held After
51,632
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$574.03
Total Value
$114.81K
Shares Held After
53,272
% of Holdings
0.4%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
6,374
Price
$6.48
Total Value
$41.30K
Shares Held After
395,517
% of Holdings
1.6%
IONIS PHARMACEUTICALS INC (IONS)
PARSHALL B LYNNE — Director
Shares
534
Price
$76.97
Total Value
$41.10K
Shares Held After
51,344
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
PARSHALL B LYNNE — Director
Shares
4,466
Price
$76.19
Total Value
$340.26K
Shares Held After
51,878
% of Holdings
7.9%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
120,000
Price
$150.09
Total Value
$18.01M
Shares Held After
276,698
% of Holdings
30.2%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
326
Price
$25.86
Total Value
$8.43K
Shares Held After
174,209
% of Holdings
0.2%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
1,101
Price
$25.24
Total Value
$27.79K
Shares Held After
174,535
% of Holdings
0.6%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
2,573
Price
$23.76
Total Value
$61.12K
Shares Held After
175,636
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
1,730
Price
$26.82
Total Value
$46.40K
Shares Held After
297,940
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
3,316
Price
$26.61
Total Value
$88.24K
Shares Held After
256,612
% of Holdings
1.3%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
3,590
Price
$26.61
Total Value
$95.53K
Shares Held After
251,054
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
2,806
Price
$26.87
Total Value
$75.40K
Shares Held After
392,743
% of Holdings
0.7%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
1,529
Price
$26.80
Total Value
$40.98K
Shares Held After
190,463
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,668
Price
$6.29
Total Value
$261.95K
Shares Held After
1,795,614
% of Holdings
2.3%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
81,840
Price
$20.27
Total Value
$1.66M
Shares Held After
4,562,546
% of Holdings
1.8%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
8,593
Price
$26.90
Total Value
$231.15K
Shares Held After
316,466
% of Holdings
2.6%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
9,135
Price
$26.93
Total Value
$246.01K
Shares Held After
1,640,616
% of Holdings
0.6%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
4,308
% of Holdings
46.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
100
Price
$130.33
Total Value
$13.03K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
639
Price
$129.17
Total Value
$82.54K
Shares Held After
100
% of Holdings
86.5%
Showing 401–450 of 1061 transactions (page 9 of 22)